Cover Image
市場調查報告書

放射線腫瘤手術機器人的全球市場 (2016∼2022年):佔有率、策略、預測

Radiology Oncology Surgical Robots: Market Shares, Strategies, and Forecasts, Worldwide, 2016-2022

出版商 WinterGreen Research, Inc. 商品編碼 348636
出版日期 內容資訊 英文 557 Pages
訂單完成後即時交付
價格
Back to Top
放射線腫瘤手術機器人的全球市場 (2016∼2022年):佔有率、策略、預測 Radiology Oncology Surgical Robots: Market Shares, Strategies, and Forecasts, Worldwide, 2016-2022
出版日期: 2016年01月06日 內容資訊: 英文 557 Pages
簡介

放射線腫瘤市場由於高齡化和新技術的登場而全球擴大。放射線腫瘤手術機器人設備市場,預計從2015年的40億美元到2022年達到73億美元。

本報告提供全球放射線腫瘤手術機器人市場相關調查、市場概要與成長預測、產品概要、研究開發趨勢,及參與企業簡介等彙整資料。

摘要整理

第1章 市場概要與趨勢

  • 放射線治療、放射線手術、近距離放射治療
  • 目前放射線治療的限制
  • 放射線機器人手術臨床設施與臨床診斷
  • 腦瘤

第2章 市場佔有率與市場預測

  • 市場促進力
  • 市場佔有率分析
  • 台數分析
  • 治療數量
  • 各地區分析

第3章 產品概要

  • Accuray CyberKnife M6系列
  • Elekta
  • Varian
  • ViewRay

第4章 技術及研究

第5章 企業概要

  • Accuray
  • Best Theratronics, Ltd
  • Brainlab AG
  • Elekta
  • Mitsubishi Heavy Industries
  • Varian Medical Systems
  • ViewRay
  • Accuray Locations
  • 二元X光設備的主要供應商
目錄
Product Code: SH26564999

Worldwide Radiology Oncology surgical robot markets are poised to achieve significant growth as next generation systems provide a way to improve traditional open surgery and use radiology for cancer surgery. New systems pinpoint the delivery of radiation precisely, eliminating the radiological overdosing that has been such a problem previously, limiting the quantity of radiation that can be delivered.

Radiosurgery robots take cancer surgery far beyond what has been available, promising a cure for cancer. Radiology oncology surgical robots use mechanical mobility and continuous image guidance to remove tumors. The Accuray CyberKnife® robotic system follows the oncology target throughout treatment, intelligently delivering sub-millimeter precision, sparing healthy tissue. A robotic manipulator and a compact, lightweight linear accelerator, can deliver beams from thousands of non-coplanar, isocentric or non-isocentric angles. Treatments have excellent tumor coverage, steep dose gradients, and tight dose conformality.

The radiation oncology market is growing globally due to a number of factors centered around the aging of the population and the benefits accrued from new technology. The number of new cancer cases diagnosed annually is projected to increase from 14.9 million in 2015 to 20 million by 2025. The increase in new cases is due to a steadily aging population. Both developed and developing countries have aging populations.

Technology advances improve the precision and applicability of radiotherapy and radiosurgery. Expanding uses of radiotherapy and radiosurgery equipment occur because the units are able to treat a broader range of cases. Advances in hardware and software are creating a market for replacing an aging installed base. New designs are able to deliver higher standards of care.

The rise in cancer cases, together with the increase in sophistication of new treatment protocols, have created demand for more automated products. Automation depends on integration of several devices into clinically practical systems. Integrated systems make treatments rapid and cost effective.

Technology advances lead to improvements in patient care. The availability of advanced, automated and efficient clinical tools in radiation therapy has brought more precise forms of radiotherapy treatment (IMRT, IGRT, VMAT, SRS, SBRT, brachytherapy and proton therapy). Technology includes the EDGE™ and Truebeam™, and the Accuray TomoTherapy H Series and CyberKnife M6 platforms that enable treatments that reduce treatment times and increase patient throughput .

International markets are under-equipped to address the growing cancer incidence. Patients in many foreign countries must frequently endure long waits for radiotherapy.

9,000 additional treatment machines will be required by 2020 in developing countries. China, India and Brazil are estimated to require over 3,800, 1,200 and 400 additional machines. Demand in emerging markets, coupled with ever increasing incidences of cancer, represent additional drivers for continued growth.

Radiology oncology surgical robot market driving forces relate to an opportunity to achieve change in medical practice regarding the treatment of cancer. Change would lead to utilization of stereotactic body radiosurgery more regularly as an alternative to surgery or other treatments. Radiosurgery is poised to revolutionize the treatment of cancer by eradicating tumors while not harming surrounding healthy tissue.

The ability to use high doses of radiation to precisely eliminate a tumor while leaving healthy tissue unharmed is compelling. It means that high doses of radiation can be delivered without killing the person, that doses of radiation delivered can be enough to kill the cancer without killing the person, this represents a change in what has been possible previously.

The Varian, Elekta, and Accuray radiology oncology surgical devices offer robust clinical treatment capabilities. Flexibility of the Accuray InCise™ Multileaf Collimator and robotic delivery permit treatment of tumors previously thought untreatable. With radiosurgery and SBRT cancer can be treated efficiently and effectively. The device offers accuracy.

According to Susan Eustis, lead author of the study, "Existing open brain and abdominal cancer surgery can be replaced in large part during the forecast period by robotic radiological oncology surgery. Radiologic robotic surgical approaches complement existing open surgery techniques, but will replace them as more physicians and surgeons become skilled in manipulating the x-ray devices. Soon, all oncology surgery will be considered in the context of what part of the oncology procedure will be undertaken with at least some aspects of robotic radiologic surgery replacing or complementing open cancer surgery.

The aging US population has supported demand for robotic Radiology Oncology surgery. Since the occurrence of health issues that require medical devices is higher in the elderly population the more astute baby boomers have been looking to understand what surgical alternatives are open to them. . Buoyed by strong demand and sales, industry profit margins have increased considerably during the past five years.

Hospitals are adopting robotic surgical devices to improve their outcomes numbers. Hospitals are measured on outcomes, robots for surgery, when used by a trained physician are improving outcomes significantly. Hundreds of universities worldwide have research programs in robotics and many are awarding degrees in robotics. These "roboticists" are increasingly being hired by Global 2000 organizations to link mobile robots (mobile computers) into existing IT systems.

Robot-assisted surgery gives the surgeon better control over the surgical instruments and a better view of the surgical site. Surgeons no longer have to stand throughout the surgery and do not tire as quickly. Hand tremors are filtered out by the robot's computer software. The surgical robot can continuously be used by rotating surgery teams.

Radiology Oncology surgical robot device markets at $4 billion in 2015 are anticipated to reach $7.3 billion by 2022 as next generation devices, systems, and instruments are introduced to manage cancer surgery through radiation excision that eliminates open cutting in the body. Patients tolerate the surgery well, walking out of the hospital after the procedure no longer bothered by healing or infection from an incision.

The complete report provides a comprehensive analysis including procedure numbers, units sold, market value, forecasts, as well as a detailed competitive market shares and analysis of major players' success, challenges, and strategies in each segment and sub-segment. The reports cover markets for Radiology Oncology robotic surgery medical specialties and sub-specialties.

Table of Contents

Radiology Oncology Surgical Robot Executive Summary

  • Radiology Oncology Surgical Robot Market Driving Forces
    • Surgical Radiology Robotics Market Driving Forces
    • Radiology Surgical Robot Key Procedures As Elements Of Strategy
    • Radiosurgery As Stereotactic Radiotherapy
  • Radiology Oncology Surgical Robots Market Share Analysis
  • Radiology Surgical Robots Market Forecasts

1. Radiology Surgical Robot Market Description and Market Dynamics

  • 1.1 Radiotherapy, Radiation Therapy, Radiosurgery, And Brachytherapy Market Description
    • 1.1.1 IMRT
    • 1.1.2 VMAT
    • 1.1.3 IGRT
    • 1.1.4 SRS and SBRT
    • 1.1.5 Brachytherapy
    • 1.1.6 Proton Therapy
  • 1.2 Current Radiation Therapy Limitations
  • 1.3 Radiology Robotic Surgical Clinical Facilities and Clinical Diagnosis
    • 1.3.1 Cancer Robotic Surgery Learning Curves
    • 1.3.2 Robotic Radiological Surgery Equipment
    • 1.3.3 Medicare and Medicaid Impact
    • 1.3.4 Medical Robotic Surgery by Segment
    • 1.3.5 Robotic Cancer Surgery
    • 1.3.6 Cancer
  • 1.4 Brain Tumors
    • 1.4.1 Causes of Brain Tumor
    • 1.4.2 Tumor Grading
    • 1.4.3 Types of Treatment
    • 1.4.4 Biopsies
    • 1.4.5 U.S. Markets For Diagnostic Oncology-Related X-Ray-Based Imaging Products
    • 2D X-Ray Systems Market Driving Forces

2. Radiology Oncology Surgical Robot Market Shares and Market Forecasts

  • 2.1 Radiology Oncology Surgical Robot Market Driving Forces
    • 2.1.1 Surgical Radiology Robotics Market Driving Forces
    • 2.1.2 Radiology Surgical Robot Key Procedures As Elements Of Strategy
    • 2.1.3 Radiosurgery Is Stereotactic Radiotherapy
  • 2.2 Radiology Oncology Surgical Robots Market Share Analysis
    • 2.2.1 Accuray
    • 2.2.2 Accuray Clinical Studies
    • 2.2.3 Accuray Goal
    • 2.2.4 Accuray Revenue
    • 2.2.5 Varian
    • 2.2.6 Elekta
    • 2.2.7 Brainlab
    • 2.2.8 Radiology Surgical Robots Market Unit Analysis
  • 2.3 Radiology Surgical Robots Market Forecasts
    • 2.3.1 Advanced Surgical Robotic Radiation Therapy Systems
    • 2.3.2 U.S. Markets For Diagnostic Oncology-Related X-Ray-Based Imaging Products 87
  • 2.4 Cancer Incidence and Radiology Surgery Number of Procedures
  • 2.5 Radiology Surgical Robots Regional Analysis
    • 2.5.1 US Radiation Oncology Market
    • 2.5.2 European Radiation Oncology Market
    • 2.5.3 Asia Pacific Market Radiation Oncology Market
    • 2.5.4 Accuray in China
    • 2.5.5 Advantages of the Accuray Cyberknife treatment in China
    • 2.5.6 GE Moves X-Ray Base to China to Tap Growth
    • 2.5.7 Japanese Regulatory Approval for Accuray CyberKnife Robotic Full-body Radiosurgery System
    • 2.5.8 Japan X-ray Systems Market
    • 2.5.9 Philips Expands Global Reach Of X-Ray Solutions
    • 2.5.10 Reimbursement Challenges

3. Radiology Surgical Robots Product Descriptions

  • 3.1 Accuray CyberKnife M6 Series
    • 3.1.1 Accuray CyberKnife M6 FIM System
    • 3.1.2 Accuray CyberKnife® M6™ System
    • 3.1.3 Accuray / CyberKnife VSI System
    • 3.1.4 Accuray / TomoTherapy System
    • 3.1.5 Accuray Clinical Studies
    • 3.1.6 Accuray TomoTherapy® System Clinical Studies
    • 3.1.7 Accuray CyberKnife® System Clinical Study
    • 3.1.8 Accuray TomoTherapy System Clinical Study
    • 3.1.9 Class A User Licenses for Accuray Products Awarded to 16 Hospitals in China
    • 3.1.10 Accuray "Open Systems" Software Benefits
  • 3.2 Elekta
    • 3.2.1 Elekta Gamma Knife® Surgery
  • 3.3 Varian
    • 3.3.1 Varian Image Guided Radiation Therapy, Cone-Beam CT (CBCT
    • 3.3.2 Varian Trilogy
    • 3.3.3 Varian Edge™ Radiosurgery Suite
    • 3.3.4 Varian Oncology Systems
  • 3.4 ViewRay

4. Radiology Surgical Robots Technology and Research

  • 4.1.1 Fiducial Markers Implantation
    • 4.1.2 Molding Of A Plastic Body Cradle
    • 4.1.3 Treatment Planning
    • 4.1.4 Programming of the Accuray Cyberknife System
    • 4.1.5 Treatment Procedure
    • 4.1.6 Postoperative Supervision
  • 4.2 Varian Medical TrueBeam® Systems Advanced Platform
    • 4.2.1 Potential of High Definition Radiotherapy
  • 4.3 C-Arm Surgical X-Rays
  • 4.4 X-Ray Digital Workflow
  • 4.5 Stereotactic Radiosurgery
    • 4.5.1 Image-Guided Stereotactic Radiosurgery
    • 4.5.2 Image-Guided Stereotactic Radiosurgery Safety
  • 4.6 Siemens Ysio Max (Advances in X-Ray)
  • 4.7 MD Anderson Gamma Knife Radiosurgery
    • 4.7.1 MD Anderson Proton Therapy Center
  • 4.8 Partners Healthcare Massachusetts General Hospital Radiation Cancer Treatment
    • 4.8.1 Partners Healthcare / Dana Farber
    • 4.8.2 Three-Dimensional Conformal Radiation Therapy (3D-CRT)
    • 4.8.3 Image Guided Radiation Therapy (IGRT)
    • 4.8.4 Intensity Modulated Radiation Therapy (IMRT)
    • 4.8.5 RapidArc™ Volumetric Modulated Radiotherapy
    • 4.8.6 Total Body Irradiation (TBI)
    • 4.8.7 Accelerated Whole Breast Radiation Therapy
    • 4.8.8 Stereotactic Radiosurgery (SRS)
    • 4.8.9 High Dose Rate (HDR) Brachytherapy
    • 4.8.10 Robotic Transrectal Ultrasound (TRUS) Guided Radiation Therapy
  • 4.9 Memorial Sloan Kettering Radiation Cancer Treatment
    • 4.9.1 Memorial Sloan Kettering IMRT & IGRT
    • 4.9.2 Memorial Sloan Kettering Stereotactic Radiation Therapy
    • 4.9.3 Memorial Sloan Kettering Whole-Brain Radiation Therapy Stereotactic Radiosurgery, SRS
  • 4.10 U.S. Regulations
    • 4.10.1 Foreign Regulations

5. Radiology Surgical Robots Company Descriptions

  • 5.1 Accuray
    • 5.1.1 Accuray Revenue for Second Quarter of Fiscal Year 2015
    • 5.1.2 Accuray Revenue Three Months Ended September 30, 2015
    • 5.1.3 Accuray Revenue
    • 5.1.4 Accuray Non-Invasively Delivers High Doses Of Radiation To Tumors With Extreme Accuracy And Intense Precision
    • 5.1.5 Accuray Products
    • 5.1.6 Accuray CyberKnife System
    • 5.1.7 Accuray Strategy
    • 5.1.8 Accuray International Presence
    • 5.1.9 Accuray Competition
    • 5.1.10 New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 195
    • 5.1.11 Accuray Recall in 2013
  • 5.2 Best Theratronics, Ltd
  • 5.3 Brainlab AG
    • 5.3.1 Brainlab AG Revenue
    • 5.3.2 Brainlab
  • 5.4 Elekta
    • 5.4.1 Elekta Gamma Radio Surgery System
    • 5.4.2 Elekta - Interim report May - October 2015/16
    • 5.4.3 Elekta Transformation program on track
  • 5.5 Mitsubishi Heavy Industries
    • 5.5.1 Mitsubishi Heavy Industries Vero Sterotactic Body Radiotherapy
  • 5.6 Varian Medical Systems
    • 5.6.1 Varian Oncology Systems Business Segment
    • 5.6.2 Varian Revenue
  • 5.7 ViewRay
  • 5.8 Accuray Locations
  • 5.9 2D X-ray Equipment Leading Vendors
  • Table ES-1 Innovative Radiology Surgical Robot Features
  • Table ES-2 Surgical Robotics Market Driving Forces
  • Table ES-3 Radiology Surgical Robot Market Positioning
  • Table ES-4 Accuray CyberKnife M6 Series Systems Adoption Trends
  • Table ES-5 Radiological Surgical Robot Medical Sub-Specialties
  • Figure ES-6 Radiology Surgical Robots Market Shares, Shipments, Dollars, Worldwide 2015
  • Figure ES-7 Radiology Surgical Robot Systems Forecasts, Dollars, Worldwide, 2015-2021
  • Table 1-1 Current Radiation Therapy Process and Limitations
  • Table 1-2 Advanced Clinical Decision Support
  • Table 1-3 Radiological Surgical Robots Benefits
  • Figure 1-4 X-ray Diagnosing and Tracking Cancer
  • Table 1-5 Factors That May Increase The Risk Of Complications With Radiology Cancer Surgery
  • Table 1-6 X-Ray Equipment Market Driving Forces
  • Table 2-1 Innovative Radiology Surgical Robot Features
  • Table 2-2 Surgical Robotics Market Driving Forces
  • Table 2-3 Radiology Surgical Robot Market Positioning
  • Table 2-4 Accuray CyberKnife M6 Series Systems Adoption Trends
  • Table 2-5 Radiological Surgical Robot Medical Sub-Specialties
  • Figure 2-6 Radiology Surgical Robots Market Shares, Shipments, Dollars, Worldwide 2015
  • Table 2-7 Radiology Surgical Linear Accelerator Market Shares, Dollars, Worldwide, 2015
  • Figure 2-8 Accuray Patient Station
  • Table 2-9 Accuray CyberKnife Features
  • Table 2-10 Accuray Regional Revenue Shifts
  • Table 2-11 Elekta Gamma Knife Benefits
  • Table 2-12 Elekta Gamma Knife® Positioning
  • Table 2-13 Elekta Gamma Knife Perfexion Treatment Benefits
  • Table 2-14 Elekta Gamma Knife Features
  • Table 2-15 Radiology Surgical Linear Accelerator, Market Shares, Units and Dollars, Worldwide, 2015
  • Figure 2-16 Radiology Surgical Robot Systems Forecasts, Dollars, Worldwide, 2016-2022
  • Table 2-17 Radiology Surgical Robot Market Segment Forecasts, Dollars and Units, Worldwide, 2016-2022
  • Table 2-18 New Cancer Cases in US, 2015, 1,658 Thousand
  • Figure 2-19 Cancer Incidence and Mortality, Worldwide
  • Table 2-20 Accuray Surgical Robotic Advantages
  • Figure 2-21 Radiology Surgical Robots Regional Analysis
  • Table 2-22 Radiology Surgical Robots Market Segments
  • Table 2-23 Accuray Regional Revenue Shifts
  • Table 2-24 Accuray Cyberknife Radiosurgery System Treats The Following Diseases In China: 98
  • Table 2-25 Advantages of the Cyberknife Treatment in China
  • Table 3-1 Accuray CyberKnife M6 Series Benefits:
  • Table 3-2 Accuray CyberKnife M6 Series Functions
  • Table 3-3 Accuray CyberKnife M6 Series Uses
  • Table 3-4 Accuray CyberKnife M6 Series Features
  • Table 3-5 Accuray CyberKnife M6 Patient Comfort Features
  • Figure 3-6 Accuray Radiology Surgical Robot
  • Figure 3-7 Accuray CyberKnife M6 FIM System
  • Table 3-8 Accuray CyberKnife M6 FIM System Features
  • Figure 3-9 Accuray CyberKnife M6 FM System
  • Table 3-10 Accuray CyberKnife M6 FM System Design Features
  • Figure 3-11 Accuray CyberKnife M6 FI System
  • Figure 3-12 Accuray / CyberKnife VSI System
  • Table 3-13 Accuray CyberKnife VSI™ Radiosurgery System Functions
  • Table 3-14 Accuray CyberKnife VSI™ Radiosurgery System Treatment Options
  • Figure 3-15 Accuray TomoTherapy® System
  • Table 3-16 Accuray TomoTherapy System Benefits
  • Table 3-17 Accuray Cancer Conditions Treated via Surgical Robot
  • Table 3-18 Accuray Open Systems Software Benefits
  • Table 3-19 Accuray Open Systems Software Challenges
  • Figure 3-20 Human Brain with Cancer Tumors
  • Figure 3-21 Elekta Lexsell Gamma Knife® PERFEXIONTM System
  • Table 3-22 Conditions for Elekta Gamma Knife® Efficacy
  • Table 3-23 Advantages of Elekta Gamma Knife®
  • Figure 3-24 Elekta Market Leading Solutions Portfolio
  • Figure 3-25 Varian Radiosurgery System
  • Figure 3-26 Varian Radiation Surgery Capabilities
  • Figure 3-27 Varian Trilogy
  • Table 3-28 Varian Oncology Product Set
  • Table 3-28 (Continued) Varian Oncology Product Set
  • Figure 3-29 ViewRay On-Table Dose Prediction And Re-Optimization
  • Figure 3-30 ViewRay MRIdian® System
  • Table 3-31 ViewRay MRIdian® System Functions
  • Figure 4-1 X-Ray Digital Workflow
  • Figure 4-2 Digital X-Ray Equ9pm3n35 Part of Paperless Workflow in Hospital
  • Figure 4-3 Departmental Picture Archiving And Communication System PACS: Clinical Productivity
  • Table 4-4 Elekta Gamma Knife Surgery Targets Accuray Regional Revenue Shifts
  • Table 5-1 Accuray Strategy
  • Table 5-2 Accuray Key Elements Of Strategy
  • Table 5-3 Best Theratronics, Ltd Radiation Therapy - Gammabeam™ 500 Total Body Irradiator Features
  • Figure 5-4 Best Theratronics, Ltd Radiation Therapy - Gammabeam™ 500 Total Body Irradiator
  • Figure 5-5 Brainlab Collaborative Workspace
  • Figure 5-6 Brainlab AG Worldwide Presence, Headquarters in Germany
  • Figure 5-7 Elekta Gamma Radio Surgery System
  • Figure 5-8 Mitsubishi Heavy Industries Vero RadioTherapy
  • Table 5-9 ViewRay Early Adopters:
Back to Top